- Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials. Leukemia & lymphoma. 2017 In Process GET IT
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 17
- Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
Times cited: 26
- Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Human gene therapy. 2014 Information Resource GET IT
- Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer Journal for Clinicians. 2012 Information Resource GET IT
- Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study. Clinical lymphoma, myeloma & leukemia. 2012 Academic Article GET IT
- Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management. Clinical Advances in Hematology and Oncology. 2011 Academic Article GET IT
- Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.
Leukemia & lymphoma.
Times cited: 18
Chromosomal and gene amplification in diffuse large B-cell lymphoma.
Times cited: 239